Breathonix is an NUS spin-off that develops rapid, non-invasive breath tests for early disease detection. Its proprietary breath analysis technology detects volatile organic compounds (VOCs) within minutes, enabling fast and accurate screening for conditions such as lung cancer and infectious diseases.